The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AI Drug Discovery Platform Market Research Report 2025
Synopsis
Global AI Drug Discovery Platform market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI Drug Discovery Platform market research.
Key companies engaged in the AI Drug Discovery Platform industry include Exscientia, Iktos, Delta4, Healx, Innoplexus, BenevolentAI, Evaxion, Genome Biologics and Novadiscovery, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of AI Drug Discovery Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole AI Drug Discovery Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI Drug Discovery Platform market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Exscientia
Iktos
Delta4
Healx
Innoplexus
BenevolentAI
Evaxion
Genome Biologics
Novadiscovery
Nuritas
CytoReason
Turbine Simulated Cell Technologies
Atomwise
Recursion
Insilico Medicine
Relay Therapeutics
Pfizer
Janssen
AstraZeneca
Beijing Iipharma
Segment by Type
Drug Discovery
Drug Design
Segment by Application
Pharmaceutical Company
Biotech Company
Contract Research Organization
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI Drug Discovery Platform report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global AI Drug Discovery Platform market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI Drug Discovery Platform market research.
Key companies engaged in the AI Drug Discovery Platform industry include Exscientia, Iktos, Delta4, Healx, Innoplexus, BenevolentAI, Evaxion, Genome Biologics and Novadiscovery, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of AI Drug Discovery Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole AI Drug Discovery Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI Drug Discovery Platform market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Exscientia
Iktos
Delta4
Healx
Innoplexus
BenevolentAI
Evaxion
Genome Biologics
Novadiscovery
Nuritas
CytoReason
Turbine Simulated Cell Technologies
Atomwise
Recursion
Insilico Medicine
Relay Therapeutics
Pfizer
Janssen
AstraZeneca
Beijing Iipharma
Segment by Type
Drug Discovery
Drug Design
Segment by Application
Pharmaceutical Company
Biotech Company
Contract Research Organization
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI Drug Discovery Platform report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Discovery Platform Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Drug Discovery
1.2.3 Drug Design
1.3 Market by Application
1.3.1 Global AI Drug Discovery Platform Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Company
1.3.3 Biotech Company
1.3.4 Contract Research Organization
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Discovery Platform Market Perspective (2018-2029)
2.2 AI Drug Discovery Platform Growth Trends by Region
2.2.1 Global AI Drug Discovery Platform Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 AI Drug Discovery Platform Historic Market Size by Region (2018-2023)
2.2.3 AI Drug Discovery Platform Forecasted Market Size by Region (2024-2029)
2.3 AI Drug Discovery Platform Market Dynamics
2.3.1 AI Drug Discovery Platform Industry Trends
2.3.2 AI Drug Discovery Platform Market Drivers
2.3.3 AI Drug Discovery Platform Market Challenges
2.3.4 AI Drug Discovery Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Drug Discovery Platform Players by Revenue
3.1.1 Global Top AI Drug Discovery Platform Players by Revenue (2018-2023)
3.1.2 Global AI Drug Discovery Platform Revenue Market Share by Players (2018-2023)
3.2 Global AI Drug Discovery Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Drug Discovery Platform Revenue
3.4 Global AI Drug Discovery Platform Market Concentration Ratio
3.4.1 Global AI Drug Discovery Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Discovery Platform Revenue in 2022
3.5 AI Drug Discovery Platform Key Players Head office and Area Served
3.6 Key Players AI Drug Discovery Platform Product Solution and Service
3.7 Date of Enter into AI Drug Discovery Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Discovery Platform Breakdown Data by Type
4.1 Global AI Drug Discovery Platform Historic Market Size by Type (2018-2023)
4.2 Global AI Drug Discovery Platform Forecasted Market Size by Type (2024-2029)
5 AI Drug Discovery Platform Breakdown Data by Application
5.1 Global AI Drug Discovery Platform Historic Market Size by Application (2018-2023)
5.2 Global AI Drug Discovery Platform Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America AI Drug Discovery Platform Market Size (2018-2029)
6.2 North America AI Drug Discovery Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America AI Drug Discovery Platform Market Size by Country (2018-2023)
6.4 North America AI Drug Discovery Platform Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Drug Discovery Platform Market Size (2018-2029)
7.2 Europe AI Drug Discovery Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe AI Drug Discovery Platform Market Size by Country (2018-2023)
7.4 Europe AI Drug Discovery Platform Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Drug Discovery Platform Market Size (2018-2029)
8.2 Asia-Pacific AI Drug Discovery Platform Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific AI Drug Discovery Platform Market Size by Region (2018-2023)
8.4 Asia-Pacific AI Drug Discovery Platform Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Drug Discovery Platform Market Size (2018-2029)
9.2 Latin America AI Drug Discovery Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America AI Drug Discovery Platform Market Size by Country (2018-2023)
9.4 Latin America AI Drug Discovery Platform Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Drug Discovery Platform Market Size (2018-2029)
10.2 Middle East & Africa AI Drug Discovery Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa AI Drug Discovery Platform Market Size by Country (2018-2023)
10.4 Middle East & Africa AI Drug Discovery Platform Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exscientia
11.1.1 Exscientia Company Detail
11.1.2 Exscientia Business Overview
11.1.3 Exscientia AI Drug Discovery Platform Introduction
11.1.4 Exscientia Revenue in AI Drug Discovery Platform Business (2018-2023)
11.1.5 Exscientia Recent Development
11.2 Iktos
11.2.1 Iktos Company Detail
11.2.2 Iktos Business Overview
11.2.3 Iktos AI Drug Discovery Platform Introduction
11.2.4 Iktos Revenue in AI Drug Discovery Platform Business (2018-2023)
11.2.5 Iktos Recent Development
11.3 Delta4
11.3.1 Delta4 Company Detail
11.3.2 Delta4 Business Overview
11.3.3 Delta4 AI Drug Discovery Platform Introduction
11.3.4 Delta4 Revenue in AI Drug Discovery Platform Business (2018-2023)
11.3.5 Delta4 Recent Development
11.4 Healx
11.4.1 Healx Company Detail
11.4.2 Healx Business Overview
11.4.3 Healx AI Drug Discovery Platform Introduction
11.4.4 Healx Revenue in AI Drug Discovery Platform Business (2018-2023)
11.4.5 Healx Recent Development
11.5 Innoplexus
11.5.1 Innoplexus Company Detail
11.5.2 Innoplexus Business Overview
11.5.3 Innoplexus AI Drug Discovery Platform Introduction
11.5.4 Innoplexus Revenue in AI Drug Discovery Platform Business (2018-2023)
11.5.5 Innoplexus Recent Development
11.6 BenevolentAI
11.6.1 BenevolentAI Company Detail
11.6.2 BenevolentAI Business Overview
11.6.3 BenevolentAI AI Drug Discovery Platform Introduction
11.6.4 BenevolentAI Revenue in AI Drug Discovery Platform Business (2018-2023)
11.6.5 BenevolentAI Recent Development
11.7 Evaxion
11.7.1 Evaxion Company Detail
11.7.2 Evaxion Business Overview
11.7.3 Evaxion AI Drug Discovery Platform Introduction
11.7.4 Evaxion Revenue in AI Drug Discovery Platform Business (2018-2023)
11.7.5 Evaxion Recent Development
11.8 Genome Biologics
11.8.1 Genome Biologics Company Detail
11.8.2 Genome Biologics Business Overview
11.8.3 Genome Biologics AI Drug Discovery Platform Introduction
11.8.4 Genome Biologics Revenue in AI Drug Discovery Platform Business (2018-2023)
11.8.5 Genome Biologics Recent Development
11.9 Novadiscovery
11.9.1 Novadiscovery Company Detail
11.9.2 Novadiscovery Business Overview
11.9.3 Novadiscovery AI Drug Discovery Platform Introduction
11.9.4 Novadiscovery Revenue in AI Drug Discovery Platform Business (2018-2023)
11.9.5 Novadiscovery Recent Development
11.10 Nuritas
11.10.1 Nuritas Company Detail
11.10.2 Nuritas Business Overview
11.10.3 Nuritas AI Drug Discovery Platform Introduction
11.10.4 Nuritas Revenue in AI Drug Discovery Platform Business (2018-2023)
11.10.5 Nuritas Recent Development
11.11 CytoReason
11.11.1 CytoReason Company Detail
11.11.2 CytoReason Business Overview
11.11.3 CytoReason AI Drug Discovery Platform Introduction
11.11.4 CytoReason Revenue in AI Drug Discovery Platform Business (2018-2023)
11.11.5 CytoReason Recent Development
11.12 Turbine Simulated Cell Technologies
11.12.1 Turbine Simulated Cell Technologies Company Detail
11.12.2 Turbine Simulated Cell Technologies Business Overview
11.12.3 Turbine Simulated Cell Technologies AI Drug Discovery Platform Introduction
11.12.4 Turbine Simulated Cell Technologies Revenue in AI Drug Discovery Platform Business (2018-2023)
11.12.5 Turbine Simulated Cell Technologies Recent Development
11.13 Atomwise
11.13.1 Atomwise Company Detail
11.13.2 Atomwise Business Overview
11.13.3 Atomwise AI Drug Discovery Platform Introduction
11.13.4 Atomwise Revenue in AI Drug Discovery Platform Business (2018-2023)
11.13.5 Atomwise Recent Development
11.14 Recursion
11.14.1 Recursion Company Detail
11.14.2 Recursion Business Overview
11.14.3 Recursion AI Drug Discovery Platform Introduction
11.14.4 Recursion Revenue in AI Drug Discovery Platform Business (2018-2023)
11.14.5 Recursion Recent Development
11.15 Insilico Medicine
11.15.1 Insilico Medicine Company Detail
11.15.2 Insilico Medicine Business Overview
11.15.3 Insilico Medicine AI Drug Discovery Platform Introduction
11.15.4 Insilico Medicine Revenue in AI Drug Discovery Platform Business (2018-2023)
11.15.5 Insilico Medicine Recent Development
11.16 Relay Therapeutics
11.16.1 Relay Therapeutics Company Detail
11.16.2 Relay Therapeutics Business Overview
11.16.3 Relay Therapeutics AI Drug Discovery Platform Introduction
11.16.4 Relay Therapeutics Revenue in AI Drug Discovery Platform Business (2018-2023)
11.16.5 Relay Therapeutics Recent Development
11.17 Pfizer
11.17.1 Pfizer Company Detail
11.17.2 Pfizer Business Overview
11.17.3 Pfizer AI Drug Discovery Platform Introduction
11.17.4 Pfizer Revenue in AI Drug Discovery Platform Business (2018-2023)
11.17.5 Pfizer Recent Development
11.18 Janssen
11.18.1 Janssen Company Detail
11.18.2 Janssen Business Overview
11.18.3 Janssen AI Drug Discovery Platform Introduction
11.18.4 Janssen Revenue in AI Drug Discovery Platform Business (2018-2023)
11.18.5 Janssen Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Detail
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca AI Drug Discovery Platform Introduction
11.19.4 AstraZeneca Revenue in AI Drug Discovery Platform Business (2018-2023)
11.19.5 AstraZeneca Recent Development
11.20 Beijing Iipharma
11.20.1 Beijing Iipharma Company Detail
11.20.2 Beijing Iipharma Business Overview
11.20.3 Beijing Iipharma AI Drug Discovery Platform Introduction
11.20.4 Beijing Iipharma Revenue in AI Drug Discovery Platform Business (2018-2023)
11.20.5 Beijing Iipharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
